MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features"

  • 2019 International Congress

    Involuntary movements with abnormal brain imaging: A Case Report

    W. Webb, P. Chapman, V. Sung, M. Dean (Birmingham, AL, USA)

    Objective: To present a case of juvenile-onset Huntington's disease (HD) with a mixed phenotype and abnormal brain imaging. Background: HD is an autosomal-dominant neurodegenerative disorder…
  • 2019 International Congress

    A Unified Staging System for Prodromal and Manifest Huntington’s disease

    A. Mohan, Z. Sun, S. Ghosh, Y. Li, Y. Cheng, J. Hu, C. Sampaio (Yorktown Heights, NY, USA)

    Objective: To develop an integrated staging methodology for Prodromal and Manifest Huntington’s disease (HD). Background: Once HD is diagnosed clinically (also known as, motor-onset/manifest), HD…
  • 2019 International Congress

    Ancillary Service Utilization and Impact in Huntington’s Disease

    J. Yomtoob, C. Yeh, D. Bega (Chicago, IL, USA)

    Objective: To determine which Huntington’s disease (HD) patient characteristics correlate with ancillary service utilization. To examine the longitudinal impact of ancillary therapies on clinical characteristics.…
  • 2019 International Congress

    Seeking regulatory feedback on novel clinical outcome assessments: a case example from the Huntington’s Disease – Regulatory Science Consortium (HD-RSC)

    A. Mullin, R. Fuller, G. Stebbins, J. Stout, A. Robbins, P. Feigenbaum, M. Roche, E. Gantman, C. Sampaio, M. Brumfield (Tucson, AZ, USA)

    Objective: To align with regulators on the utility and development strategy of novel clinical outcome assessments for use in Huntington’s disease (HD) clinical trials. Background:…
  • 2019 International Congress

    Motor assessments in HD clinical trials: Q-Motor versus the UHDRS-TMS – what did we learn from recent studies?

    R. Reilmann, R. Schubert, P. Barallon, P. Pracht, B. Habbel (Muenster, Germany)

    Objective: To review the performance of UHDRS-TMS and Q-Motor quantitative motor measures in recent placebo-controlled clinical trials. Background: The UHDRS-TMS has widely been used to…
  • 2019 International Congress

    Huntington’s disease: A case review of Sub-Saharan Africans with diverse origins

    M. Muthinja, J. Hooker (Nairobi, Kenya)

    Objective: To characterise the Huntingtons disease phenotype in Sub-saharan Africans. Background: Huntington’s disease (HD) is a debilitating neurodegenerative illness that leads to diminished cognitive function,…
  • 2019 International Congress

    Huntington’s Disease presenting as sporadic cerebellar ataxia

    GLF. Franklin, FAN. Nascimento, GMP. Pavanelli, SSM. Milano, HAT. Teive, NSL. Lima, SR. Raskin (Curitiba, Brazil)

    Objective: To describe a unique case of a woman who presented as a progressive cerebellar ataxia, with no family history of neurological diseases, that after…
  • 2019 International Congress

    A global survey on speech language therapists’ awareness to Huntington’s disease

    A. Nuzzi, S. Naor, N. Inbar, T. Gurevich, Y. Manor (Santeramo In Colle, Italy)

    Objective: To investigate the awareness and knowledge of speech and language therapists (SLTs) on Huntington’s disease (HD) worldwide, and to explore the clinical practice and…
  • 2019 International Congress

    Permanent chorea in 76-years-old female with poorly controlled diabetes

    F. Abu Ahmad, A. Socher, A. Gadoth, O. Aizenstein, A. Hilel, R. Hurvitz-Alon, N. Giladi, T. Gurevich (Tel Aviv, Israel)

    Objective: To present a unique case of a patient with hyperglycemic associated chorea showing no improvement during a long-term follow-up, despite a strict glycemic control.…
  • 2019 International Congress

    Multimodal characterization of the visual network in Huntington’s disease

    O. Odish, S. Gregory, I. Mayer, J.. Mills, E. Johnson, R. Scahill, J. Rothwell, G. Rees, J. Long, S. Tabrizi, R. Roos, M. Orth (Leiden, Netherlands)

    Objective: To examine the relationship between structural organization, functional processing and task performance of the visual system in a cohort of Huntington’s disease (HD) gene-mutation…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #29509 (not found)
  • #22661 (not found)
  • #25945 (not found)
  • #23027 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley